The role of routine followup bone scans after definitive therapy of localized prostatic cancer
The records of 100 patients with localized prostatic cancer were examined retrospectively in an effort to determine the usefulness of routine 99mtechnetium bone scans following definitive therapy with 125iodine implantation or external beam irradiation. With a mean followup of 47 months per patient 19 per cent of these patients had positive scans and an additional 15 per cent had scans that were considered equivocal. Of the 100 patients none had a positive scan in the absence of either an elevated serum acid phosphatase or bone pain. In our series the low incidence of positive scans as the sole evidence of disease progression does not support its routine use after definitive therapy for localized carcinoma of the prostate.
- Research Organization:
- Department of Urology, Eastern Virginia Medical School, Norfolk
- OSTI ID:
- 6581710
- Journal Information:
- J. Urol.; (United States), Vol. 128:3
- Country of Publication:
- United States
- Language:
- English
Similar Records
Radioimmunological imaging of metastatic prostatic cancer with 111indium-labeled monoclonal antibody PAY 276
Prostate biopsy after definitive treatment by interstitial iodine 125 implant or external beam radiation therapy
Related Subjects
PROSTATE
CARCINOMAS
SKELETON
RADIOISOTOPE SCANNING
ACID PHOSPHATASE
BLOOD SERUM
DIAGNOSTIC TECHNIQUES
EXTERNAL IRRADIATION
IODINE 125
ISOMERIC NUCLEI
PATIENTS
RADIATION SOURCE IMPLANTS
TECHNETIUM 99
THERAPY
BETA DECAY RADIOISOTOPES
BETA-MINUS DECAY RADIOISOTOPES
BODY
COUNTING TECHNIQUES
DAYS LIVING RADIOISOTOPES
DISEASES
ELECTRON CAPTURE RADIOISOTOPES
ENZYMES
ESTERASES
GLANDS
HOURS LIVING RADIOISOTOPES
HYDROLASES
IMPLANTS
INTERMEDIATE MASS NUCLEI
IODINE ISOTOPES
IRRADIATION
ISOMERIC TRANSITION ISOTOPES
ISOTOPES
MALE GENITALS
NEOPLASMS
NUCLEI
ODD-EVEN NUCLEI
ORGANS
PHOSPHATASES
RADIATION SOURCES
RADIOISOTOPES
TECHNETIUM ISOTOPES
YEARS LIVING RADIOISOTOPES
550601* - Medicine- Unsealed Radionuclides in Diagnostics